From journals and scientific sources

318 topics in this forum

1. Primary sources for data, records, papers

   By Altostrata, May 1, 2011
   • 11 replies
   • 2,985 views
   • 
   • Itzakadoozee
   • May 12

2. Important topics in Journals and Scientific Sources

   By Altostrata, May 12, 2011
   • 3 replies
   • 3,002 views
   • 
   • Altostrata
   • January 5

3. Papers about prolonged antidepressant withdrawal syndrome

   By Altostrata, May 22, 2011
   • 30 replies
   • 10,525 views
   • 
   • WiggleIt
   • November 6, 2018

4. Liver Enzymes Cytochrome P450 Drug Interaction Tables

   By Altostrata, November 17, 2011
   • 6 replies
   • 7,524 views
   • 
   • Altostrata
   • July 23, 2018

5. Official guides to tapering off psychiatric medications

   By Altostrata, December 24, 2012
   • 0 replies
   • 3,433 views
   • 
   • Altostrata
   • December 24, 2012

6. Before you start a topic in Journals....

   By Altostrata, June 29, 2012
   • 0 replies
   • 1,786 views
   • 
   • Altostrata
   • June 29, 2012

7. Aydemir, 2018 SSRI Induced Apathy Syndrome

   By Altostrata, March 1
   • 6 replies
   • 559 views
   • 
   • drugged
   • September 17

8. Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

   By Henosis, March 6
   • 28 replies
   • 2,129 views
   • 
   • ChessieCat
   • September 2

9. Hengartner, 2019,Antidepressant withdrawal – the tide is finally turning

   By Linus, August 22
   • 1 reply
   • 261 views
   • 
   • Linus
   • August 22

10. Munkholm Munkholm, 2019, Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis

    By Linus, July 1
    • 7 replies
    • 293 views
    • 
    • Onmyway
    • July 23

11. Ruhe, 2019 Comment on Horowitz, 2019 Tapering of SSRI treatment to mitigate withdrawal symptoms

    By Onmyway, June 28   

    • lancet psychiatry
    • new tapering proposal
    • (and 1 more)

      Tagged with:

      • lancet psychiatry
      • new tapering proposal
      • horrowitz and taylor response
    • 7 replies
    • 214 views
    • 
    • kayjaydee
    • June 29

12. Papers by Dr. GA Fava, long-time critic of antidepressants

    By Altostrata, June 8, 2011
    • 10 replies
    • 7,908 views
    • 
    • Shep
    • June 28

13. Fava, 2017 The Potential Role of Iatrogenic Comorbidity in the Interaction between Pharmacotherapy and Psychotherapy in Anxiety Disorders

    By Shep, June 28
    • 0 replies
    • 105 views
    • 
    • Shep
    • June 28

14. Fava, 2019 Iatrogenic Factors in Psychopathology

    By Shep, June 25
    • 0 replies
    • 133 views
    • 
    • Shep
    • June 25

15. Baldessarin, 2019 Effects of Treatment Discontinuation in Clinical Psychopharmacology.

    By Itzakadoozee, May 12
    • 5 replies
    • 399 views
    • 
    • Itzakadoozee
    • May 21

16. Khan, 2019 Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

    By Altostrata, April 9
    • 0 replies
    • 456 views
    • 
    • Altostrata
    • April 9

17. Moncrieff, 2005 Rethinking models of psychotropic drug action.

    By Altostrata, April 6
    • 0 replies
    • 193 views
    • 
    • Altostrata
    • April 6

18. Récalt, 2019 Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000-2017.

    By Altostrata, March 27
    • 0 replies
    • 216 views
    • 
    • Altostrata
    • March 27

19. Kanwaldeep, 2008 Watch for nonpsychotropics causing psychiatric side effects 1 2

    By btdt, April 23, 2014
    • 58 replies
    • 4,076 views
    • 
    • ghm2018
    • March 11

20. Veltri, 2015 Medication-induced hypokalemia

    By Altostrata, March 4
    • 0 replies
    • 104 views
    • 
    • Altostrata
    • March 4

21. Oehrberg, 1995 Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

    By Altostrata, January 27
    • 0 replies
    • 137 views
    • 
    • Altostrata
    • January 27

22. Andrews, 2012 Primum non nocere: an evolutionary analysis of whether antidepressants do more harm than good

    By Altostrata, April 25, 2012
    • 17 replies
    • 1,556 views
    • 
    • Altostrata
    • January 26

23. Maund, 2019 Managing Antidepressant Discontinuation: A Systematic Review.

    By Altostrata, January 26
    • 0 replies
    • 214 views
    • 
    • Altostrata
    • January 26

24. Papers about Post-SSRI Sexual Disorder (PSSD) 1 2

    By Altostrata, July 5, 2011   

    • pssd
    • sexual dysfunction
    • 36 replies
    • 17,272 views
    • 
    • Altostrata
    • January 19

25. Reisman, 2017 Sexual Consequences of Post-SSRI Syndrome.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 129 views
    • 
    • Altostrata
    • January 19

26. Bala, 2018 Post-SSRI Sexual Dysfunction: A Literature Review.

    By Altostrata, January 19   

    • pssd
    • sexual dysfunction
    • 0 replies
    • 156 views
    • 
    • Altostrata
    • January 19

27. Papp, 2018 Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.

    By Altostrata, January 5
    • 3 replies
    • 299 views
    • 
    • Linus
    • January 16

28. Harvey, 2014 New insights on antidepressant discontinuation syndrome

    By dalsaan, January 6, 2015
    • 2 replies
    • 980 views
    • 
    • Linus
    • January 16

29. Attfield, 2016 Preparation of Lower Dosages of SNRI Antidepressants to Ameliorate Discontinuation Symptoms: Two Case Studies

    By Andie, December 16, 2018   

    • snri
    • compounding
    • (and 5 more)

      Tagged with:

      • snri
      • compounding
      • pristiq
      • cymbalta
      • desvelafaxine
      • duloxetine
      • venlafaxine
    • 1 reply
    • 191 views
    • 
    • Altostrata
    • January 5

30. Khan, 2014 Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d.

    By Altostrata, January 5
    • 0 replies
    • 131 views
    • 
    • Altostrata
    • January 5

31. Eveleigh, 2017 Withdrawal of unnecessary antidepressant medication: a randomised controlled trial in primary care

    By Shep, November 19, 2017
    • 14 replies
    • 1,085 views
    • 
    • Altostrata
    • January 5

32. Frankel, 2018 An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.

    By Andie, December 18, 2018   

    • sert
    • pristiq
    • (and 1 more)

      Tagged with:

      • sert
      • pristiq
      • desvenlafaxine
    • 2 replies
    • 215 views
    • 
    • Altostrata
    • January 5

33. Berwian, 2017 Predicting relapse after antidepressant withdrawal - a systematic review.

    By Altostrata, September 11, 2018
    • 5 replies
    • 343 views
    • 
    • Altostrata
    • January 1

34. Jha, 2018 When Discontinuing SSRI Antidepressants Is a Challenge: Management Tips.

    By Altostrata, December 31, 2018
    • 0 replies
    • 268 views
    • 
    • Altostrata
    • December 31, 2018

35. Fornaro, 2018 The Emergence of loss of efficacy during Antidepressant Drug Treatment for Major Depressive Disorder: An Integrative Review of Evidence, Mechanisms, and Clinical Implications.

    By Altostrata, November 3, 2018   

    • tachyphylaxis
    • poop-out
    • (and 2 more)

      Tagged with:

      • tachyphylaxis
      • poop-out
      • breakthrough symptoms
      • tolerance
    • 1 reply
    • 201 views
    • 
    • Linus
    • December 22, 2018

36. Kaufmann, 2009 Selective Serotonin Reuptake Inhibitor (SSRI) Drugs: More Risks Than Benefits?

    By Altostrata, December 7, 2018
    • 0 replies
    • 225 views
    • 
    • Altostrata
    • December 7, 2018